Profile


A Phase III Open-Label Single Arm Study to Evaluate the Safety, Tolerability, and Efficancy of MK-0518/Raltegravir in a Disease Cohort of HIV-Infected Patients (055-00 MK-0518)
02/01/2003 - 01/31/2012 (PI)
Merck & Company, Inc.


A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 in Combination with an Optimized Background Therapy (OBT), Versus O
02/02/2006 - 07/31/2011 (PI)
Merck & Company, Inc.





Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Tandon R, Baranoski AS, Huang F, de las Morenas A, Vragovic O, Sullivan M, Stier EA. Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol. 2010 Jul; 203(1):21.e1-6.View Related Profiles. PMID: 20223443; PMCID: PMC2900418; DOI: 10.1016/j.ajog.2010.01.010;.
     
  2. Tandon R, Kim KS, Serrao R. Disseminated Mycobacterium avium-intracellulare infection in a person with AIDS with cutaneous and CNS lesions. AIDS Read. 2007 Nov; 17(11):555-60.View Related Profiles. PMID: 18170919.
     
  3. Tandon R, Lee M, Curran E, Demierre MF, Sulis CA. A 26-year-old woman with a rash on her extremities. Clin Infect Dis. 2006 Dec 15; 43(12):1585-6, 1616-7.View Related Profiles. PMID: 17109293.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: